MAPT and Alzheimer disease: Aβ can upregulate the generation of NFTs through Glycogen synthase kinase 3 (GSK)-3 activation, resulting in the phosphorylation of tau [109], which is more impactful on cognitive and functional decline than Aβ in AD mice [110].